Cocrystal Pharma (COCP) Operating Expenses (2010 - 2026)
Cocrystal Pharma (COCP) posted Operating Expenses of $2.6 million for Q1 2026, up 4.03% sequentially from $2.5 million in Q4 2025, and up 10.25% YoY from $2.3 million in Q1 2025.
Cocrystal Pharma (COCP) Operating Expenses (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported Operating Expenses for 16 years, with the latest figure at $2.6 million in Q1 2026.
- Quarterly Operating Expenses rose 10.25% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.3 million (down 42.35% YoY) and the FY2025 annual result came in at $9.0 million, down 49.55% from the prior year.
- Operating Expenses improved to $2.6 million in Q1 2026 per COCP's latest filing, from $2.5 million in the prior quarter.
- Over five years, Operating Expenses peaked at $24.4 million in Q2 2022 and troughed at $2.1 million in Q3 2025.
- A 5-year average of $5.1 million and a median of $4.3 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses surged 538.14% in 2022, then plunged 82.24% in 2023.
- Over 5 years, Operating Expenses stood at $4.5 million in 2022, then grew by 3.64% to $4.7 million in 2023, then slumped by 30.78% to $3.2 million in 2024, then fell by 23.19% to $2.5 million in 2025, then increased by 4.03% to $2.6 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $2.6 million, $2.5 million, and $2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.54 Bn | 130.69 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.89 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.84 Bn | 59.65 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 56.53 Bn | 51.39 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 541.02 Mn |
| 10 | Cocrystal Pharma | 15.72 Mn | 13.40 Mn | - | 3.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.29 Mn |
| Mar 31, 2026 | 2.58 Mn |
| Dec 31, 2025 | 2.48 Mn |
| Sep 30, 2025 | 2.09 Mn |
| Jun 30, 2025 | 2.11 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Dec 31, 2024 | 3.23 Mn |
| Sep 30, 2024 | 5.04 Mn |
| Jun 30, 2024 | 5.45 Mn |
| Mar 31, 2024 | 4.16 Mn |
| Dec 31, 2023 | 4.67 Mn |
| Sep 30, 2023 | 4.44 Mn |
| Jun 30, 2023 | 4.34 Mn |
| Mar 31, 2023 | 5.11 Mn |
| Dec 31, 2022 | 4.50 Mn |
| Sep 30, 2022 | 5.69 Mn |
| Jun 30, 2022 | 24.43 Mn |
| Mar 31, 2022 | 4.21 Mn |
| Dec 31, 2021 | 3.70 Mn |
| Sep 30, 2021 | 3.95 Mn |